mRNA display screening services offer advanced solutions for the selection and engineering of proteins and peptides with desired properties. This powerful technique uses a covalent link between the mRNA and the encoded protein, allowing for the creation of large, diverse libraries and high-throughput screening for binding affinity, stability, and activity. Our comprehensive services provide support from initial library construction to final candidate selection, ensuring precise and reliable results for your screening projects.
mRNA display cycle (G Kamalinia, et al.,2021)
mRNA display screening is an experimental technique used to screen protein nucleic acid interactions. This technology connects a series of mRNA encoding different proteins with specific nucleic acid sequences and transcribes and translates them in vitro, thereby binding proteins with specific nucleic acid sequences to form complexes. Then, by screening and sorting these complexes, proteins with specific binding affinity can be quickly and efficiently obtained.
This experimental method typically includes the following steps:
By using mRNA Display Screening technology, proteins with specific binding affinity can be quickly and efficiently screened, which is widely used in fields such as protein interaction research and drug screening.
The process of mRNA display screening involves several critical and interrelated steps:
For more information about our mRNA Display Screening Services or to discuss your specific needs, please contact us. Our team of experts is available to provide guidance and support for your research and biotechnological projects, ensuring you achieve your scientific and industrial goals.
The following table provides an overview of various case studies in mRNA display screening and the solutions we offer to support your research and biotechnological endeavors:
Case Study | Description | Solutions We Offer |
---|---|---|
Therapeutic Antibody Discovery | Selecting antibodies with high affinity and specificity for therapeutic use. | Library construction, mRNA display, screening, and hit identification. |
Peptide Ligand Discovery | Identifying peptides that bind specific targets with high affinity for therapeutic or diagnostic purposes. | Synthetic library design, iterative selection, and binding assays. |
Enzyme Variant Selection | Discovering enzyme variants with improved catalytic efficiency and thermal stability. | Random mutagenesis, high-throughput screening, and functional assays. |
Protein Interaction Mapping | Identifying and enhancing protein-protein interactions for signaling studies. | Library construction, mRNA display, and interaction assays. |
Ligand Binding Protein Discovery | Discovering proteins or peptides that bind specific ligands with high affinity. | Library design, mRNA display, and binding assays. |
Drug Development | Identifying and optimizing small molecules and peptides for drug discovery. | High-throughput screening, binding affinity assays, and optimization. |
A: mRNA display screening is a technique that uses a covalent link between mRNA and its encoded protein to create libraries of protein or peptide variants, allowing for high-throughput screening and selection based on binding affinity, specificity, and activity. This method is widely used for protein and peptide engineering.
A: mRNA display screening is performed through a series of steps including project consultation, library construction, mRNA display library creation, screening and selection, hit identification, characterization and validation, optimization and iteration, and reporting. Each step ensures the efficient and accurate selection of molecules with desired properties.
A: Applications include antibody discovery and engineering, peptide library screening, enzyme evolution, protein-protein interaction studies, ligand binding studies, and drug development. mRNA display screening provides powerful tools for improving and optimizing protein and peptide functions.
A: Key steps include project consultation, library construction, mRNA display library creation, screening and selection, hit identification, characterization and validation, optimization and iteration, and reporting. These steps ensure comprehensive and reliable screening of protein or peptide variants.
A: mRNA display screening is important for advancing research, developing new therapies, and improving industrial processes. It enables the high-throughput identification and optimization of molecules with enhanced properties, leading to innovative solutions in biotechnology and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.